Drug Discovery & Development’s latest article highlights how modern medical outpatient buildings (MOBs) are emerging as critical hubs for decentralized and community-based research. As sponsors seek to reach patients, these upgraded, data-ready facilities are reshaping what clinical development looks like. Headlands Research is proud to be part of this transformation. By operating high-quality research sites within next-generation outpatient settings, we’re helping expand access, improve participant diversity, and deliver the operational excellence that today’s trials demand. The article notes that our recent acquisition agreement with THL Partners reflects strong confidence in our model and supports continued investments in technology, centralized infrastructure, and site network growth. Read the full piece: https://lnkd.in/eJBp8WeQ #ClinicalResearch #OutpatientCare #ClinicalTrialSites #HeadlandsResearch
How MOBs are transforming clinical research: Headlands Research's role
This title was summarized by AI from the post below.
